VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078,494 | -67.2% | 48,298 | -62.6% | 0.00% | -100.0% |
| Q2 2023 | $3,289,909 | +327.0% | 129,168 | +273.8% | 0.00% | – |
| Q1 2023 | $770,532 | -51.8% | 34,553 | -48.8% | 0.00% | -100.0% |
| Q4 2022 | $1,600,186 | +267.9% | 67,433 | +208.4% | 0.00% | – |
| Q2 2022 | $435,000 | -55.0% | 21,866 | -37.7% | 0.00% | – |
| Q1 2022 | $967,000 | +27.9% | 35,100 | +91.2% | 0.00% | – |
| Q4 2021 | $756,000 | +156.3% | 18,359 | +189.3% | 0.00% | – |
| Q3 2021 | $295,000 | -22.4% | 6,347 | -33.3% | 0.00% | – |
| Q2 2021 | $380,000 | -47.9% | 9,511 | -29.9% | 0.00% | – |
| Q1 2021 | $729,000 | -70.4% | 13,571 | -73.1% | 0.00% | -100.0% |
| Q4 2020 | $2,466,000 | +409.5% | 50,392 | +238.2% | 0.00% | – |
| Q3 2020 | $484,000 | +131.6% | 14,902 | +85.0% | 0.00% | – |
| Q2 2020 | $209,000 | -57.4% | 8,055 | -79.4% | 0.00% | -100.0% |
| Q4 2018 | $491,000 | – | 39,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |